News Releases
- August 2, 2024
- Option Agreement for drug discovery of extracellular vesicles derived from airway epithelial cells
- July 31, 2024
- Summary of Consolidated Financial Results(For the first quarter ended June 30, 2024) [Japanese GAAP]
- July 31, 2024
- 1Q Consolidated Financial Results for the Fiscal Year Ending March 31, 2025 (September 31, 2024) - Supplementary Information
- May 21, 2024
- Notice of Dividends of Retained Earnings